TECX

Tectonic Therapeutic, Inc. is a biopharmaceutical innovator headquartered in Watertown, Massachusetts, specializing in the discovery and development of antibody-based therapies that target G-protein-coupled receptors (GPCRs), integral to numerous disease pathways. The company is dedicated to addressing significant unmet medical needs by developing novel treatment options for patients who have not responded well to current therapies. With a robust research and development pipeline, Tectonic is strategically positioned to lead advancements in biologic drugs, aiming to make impactful contributions to the therapeutic landscape.